We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Donaldson Company, Inc. (DCI - Free Report) is benefiting from solid momentum across all its segments. The Mobile Solutions segment is gaining from higher volume in the aftermarket business, driven by positive market trends and the impact of expanded market share. The Industrial Solutions segment is riding on persistent strength in the aerospace and defense business. Robust momentum in commercial aerospace fueled by increased demand for new equipment, as well as solid demand in defense markets backed by the increased orders and porting activity, augurs well for the segment. Rising demand for disk drives and food & beverage products in Europe, the Middle East and Africa, and the Asia Pacific region is boosting the Life Sciences segment.
DCI has solidified its product portfolio and leveraged business opportunities through asset additions. It acquired a 49% minority stake in Medica S.p.A. in August 2024. The inclusion of Medica’s technology and expertise in filtration products enables the company to penetrate new markets and diversify its offerings in the medical device and water purification sectors.
In June 2023, DCI acquired Univercells Technologies, expanding its growing offering in the life sciences industry. Univercells will be added to its Life Sciences segment. The company acquired Isolere Bio in February 2023. The Isolere buyout enabled Donaldson to create leading separation and filtration solutions for emerging genetically based drugs, and Isolere’s revenues are reported within the Donaldson Life Sciences segment.
The company’s shareholder-friendly policies are encouraging. Dividend payments totaled $64.6 million in the first six months of fiscal 2025 and $122.8 million in fiscal 2024. DCI bought back shares worth $81.6 million in the first six months of fiscal 2025 and $162.7 million in fiscal 2024. It is worth noting that its quarterly dividend was hiked 8% in May 2024. The company has raised its dividend for 28 consecutive years. In November 2023, its board of directors approved a new repurchase program, authorizing it to repurchase up to 12 million shares of its common stock. The new repurchase program replaced the previous one, which was approved in 2019.
The company, which belongs to the Pollution Control industry, currently carries a Zacks Rank #3 (Hold).
Donaldson has been witnessing weakness in the on-road and off-road businesses. Lower levels of global truck production owing to softness in industrial markets are affecting its on-road business. Weakness in agricultural markets and soft end-market demand globally are upsetting the off-road business. In the second quarter of fiscal 2025, the on-road and off-road business sales declined 24.4% and 12.8%, respectively, on a year-over-year basis. Management expects these weaknesses to persist in the near term and hurt the company’s performance.
DCI has been dealing with the adverse impacts of high selling, general and administrative expenses. Increasing headcount and incremental expenses associated with investments in acquired businesses are pushing up the selling, general and administrative expenses, which increased 1.5% to $159.2 million in the second quarter of fiscal 2025 and 5.7% to $636.7 million in fiscal 2024. The impact of these expenditures is evident in the rise of the selling, general and administrative expenses as a percentage of total revenues, which climbed 40 basis points to reach 18.3%. Also, the overall operating expenses increased 3.9% year over year to $369.2 million in the first six months of fiscal 2025 and 7.3% year over year to $730.3 million in fiscal 2024. The metric, as a percentage of total revenues, increased 30 basis points to 20.9%. For fiscal 2025, we expect continued pressure from rising selling, general and administrative expenses to partially dent the company’s bottom line.
DNOW delivered a trailing four-quarter average earnings surprise of 30.4%. In the past 60 days, the Zacks Consensus Estimate for DNOW’s 2025 earnings has increased 10.3%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 5.3%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has increased 0.3%.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 5.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2025 (ending June 2025) earnings has improved 0.3% in the past 60 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Donaldson Exhibits Strong Prospects Despite Persisting Headwinds
Donaldson Company, Inc. (DCI - Free Report) is benefiting from solid momentum across all its segments. The Mobile Solutions segment is gaining from higher volume in the aftermarket business, driven by positive market trends and the impact of expanded market share. The Industrial Solutions segment is riding on persistent strength in the aerospace and defense business. Robust momentum in commercial aerospace fueled by increased demand for new equipment, as well as solid demand in defense markets backed by the increased orders and porting activity, augurs well for the segment. Rising demand for disk drives and food & beverage products in Europe, the Middle East and Africa, and the Asia Pacific region is boosting the Life Sciences segment.
DCI has solidified its product portfolio and leveraged business opportunities through asset additions. It acquired a 49% minority stake in Medica S.p.A. in August 2024. The inclusion of Medica’s technology and expertise in filtration products enables the company to penetrate new markets and diversify its offerings in the medical device and water purification sectors.
In June 2023, DCI acquired Univercells Technologies, expanding its growing offering in the life sciences industry. Univercells will be added to its Life Sciences segment. The company acquired Isolere Bio in February 2023. The Isolere buyout enabled Donaldson to create leading separation and filtration solutions for emerging genetically based drugs, and Isolere’s revenues are reported within the Donaldson Life Sciences segment.
The company’s shareholder-friendly policies are encouraging. Dividend payments totaled $64.6 million in the first six months of fiscal 2025 and $122.8 million in fiscal 2024. DCI bought back shares worth $81.6 million in the first six months of fiscal 2025 and $162.7 million in fiscal 2024. It is worth noting that its quarterly dividend was hiked 8% in May 2024. The company has raised its dividend for 28 consecutive years. In November 2023, its board of directors approved a new repurchase program, authorizing it to repurchase up to 12 million shares of its common stock. The new repurchase program replaced the previous one, which was approved in 2019.
The company, which belongs to the Pollution Control industry, currently carries a Zacks Rank #3 (Hold).
Donaldson Company, Inc. Price and Consensus
Donaldson Company, Inc. price-consensus-chart | Donaldson Company, Inc. Quote
Headwinds Plaguing DCI
Donaldson has been witnessing weakness in the on-road and off-road businesses. Lower levels of global truck production owing to softness in industrial markets are affecting its on-road business. Weakness in agricultural markets and soft end-market demand globally are upsetting the off-road business. In the second quarter of fiscal 2025, the on-road and off-road business sales declined 24.4% and 12.8%, respectively, on a year-over-year basis. Management expects these weaknesses to persist in the near term and hurt the company’s performance.
DCI has been dealing with the adverse impacts of high selling, general and administrative expenses. Increasing headcount and incremental expenses associated with investments in acquired businesses are pushing up the selling, general and administrative expenses, which increased 1.5% to $159.2 million in the second quarter of fiscal 2025 and 5.7% to $636.7 million in fiscal 2024. The impact of these expenditures is evident in the rise of the selling, general and administrative expenses as a percentage of total revenues, which climbed 40 basis points to reach 18.3%. Also, the overall operating expenses increased 3.9% year over year to $369.2 million in the first six months of fiscal 2025 and 7.3% year over year to $730.3 million in fiscal 2024. The metric, as a percentage of total revenues, increased 30 basis points to 20.9%. For fiscal 2025, we expect continued pressure from rising selling, general and administrative expenses to partially dent the company’s bottom line.
Stocks to Consider
Some better-ranked companies are discussed below:
DNOW Inc. (DNOW - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DNOW delivered a trailing four-quarter average earnings surprise of 30.4%. In the past 60 days, the Zacks Consensus Estimate for DNOW’s 2025 earnings has increased 10.3%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 5.3%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has increased 0.3%.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 5.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2025 (ending June 2025) earnings has improved 0.3% in the past 60 days.